litlas
Log inCreate account

Robert S. Kerbel

Active 1971–2025

171
Papers
46,353
Citations
111
h-index
170
i10-index

Citations

Citations per year for Robert S. Kerbel1972: 6 citations1973: 7 citations1974: 13 citations1975: 10 citations1976: 6 citations1977: 2 citations1978: 2 citations1979: 5 citations1980: 10 citations1981: 8 citations1982: 12 citations1983: 10 citations1984: 23 citations1985: 16 citations1986: 7 citations1987: 16 citations1988: 25 citations1989: 19 citations1990: 37 citations1991: 18 citations1992: 13 citations1993: 29 citations1994: 36 citations1995: 54 citations1996: 72 citations1997: 92 citations1998: 152 citations1999: 187 citations2000: 331 citations2001: 348 citations2002: 398 citations2003: 481 citations2004: 530 citations2005: 447 citations2006: 598 citations2007: 519 citations2008: 595 citations2009: 610 citations2010: 634 citations2011: 628 citations2012: 536 citations2013: 462 citations2014: 395 citations2015: 351 citations2016: 389 citations2017: 359 citations2018: 282 citations2019: 1,021 citations2020: 1,030 citations2021: 1,009 citations2022: 695 citations2023: 437 citations2024: 706 citations2025: 271 citations2026: 10 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,684 citing papers, 29.9% of this breakdownChina: 1,831 citing papers, 11.7% of this breakdownCanada: 806 citing papers, 5.1% of this breakdownUnited Kingdom: 778 citing papers, 5% of this breakdownItaly: 764 citing papers, 4.9% of this breakdownGermany: 762 citing papers, 4.9% of this breakdownJapan: 537 citing papers, 3.4% of this breakdownFrance: 518 citing papers, 3.3% of this breakdownNetherlands: 352 citing papers, 2.2% of this breakdownSpain: 332 citing papers, 2.1% of this breakdownAustralia: 327 citing papers, 2.1% of this breakdownSwitzerland: 313 citing papers, 2% of this breakdown
0%29.9%Other 23.4%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology46.5%
  • Medicine38.8%
  • Immunology and Microbiology5.2%
  • Engineering3.1%
  • Materials Science1.8%
  • Neuroscience1.1%
  • Other3.5%

Topics

  • Angiogenesis and VEGF in Cancer8.3%
  • Cancer, Hypoxia, and Metabolism5.3%
  • Cancer Cells and Metastasis3.2%
  • MicroRNA in disease regulation1.9%
  • Cell Adhesion Molecules Research1.8%
  • Extracellular vesicles in disease1.6%
  • Other77.9%

Coauthors

All papers

Open in search
  1. Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa

    Authors: Kabir A. Khan, Robert S. Kerbel - Nature Reviews Clinical Oncology 2018 cited by 673

  2. Angiogenesis as a therapeutic target

    Authors: Napoleone Ferrara, Robert S. Kerbel - Nature 2005 cited by 2,649

  3. Vessel co-option in cancer

    Authors: Elizabeth A. Kuczynski, Peter Vermeulen, Francesco Pezzella, Robert S. Kerbel, Andrew R. Reynolds - Nature Reviews Clinical Oncology 2019 cited by 444

  4. Tumor Angiogenesis

    Authors: Robert S. Kerbel - New England Journal of Medicine 2008 cited by 1,929

  5. Antiangiogenic therapy in oncology: current status and future directions

    Authors: Gordon C. Jayson, Robert S. Kerbel, Lee M. Ellis, Adrian L. Harris - The Lancet 2016 cited by 836

  6. Consensus guidelines for the use and interpretation of angiogenesis assays

    Authors: Patrycja Nowak‐Sliwinska, Kari Alitalo, Elizabeth Allen, Andrey Anisimov, Alfred C. Aplin, Robert Auerbach, Hellmut G. Augustin, David O. Bates, Judy R. van Beijnum, R. Hugh F. Bender, Gabriele Bergers, Andréas Bikfalvi, Joyce Bischoff, Barbara C. Böck, Peter C. Brooks, Federico Bussolino, Bertan Cakir, Peter Carmeliet, Daniel Castranova, Anca Maria Cîmpean, Ondine Cleaver, George Coukos, George E. Davis, Michele De Palma, Anna Dimberg, Ruud P.M. Dings, Valentin Djonov, Andrew C. Dudley, Neil Dufton, Sarah‐Maria Fendt, Napoleone Ferrara, Marcus Fruttiger, Dai Fukumura, Bart Ghesquière, Yan Gong, Robert J. Griffin, Adrian L. Harris, Christopher C.W. Hughes, Nan W. Hultgren, M. Luisa Iruela‐Arispe, Melita Irving, Rakesh K. Jain, Raghu Kalluri, Joanna Kalucka, Robert S. Kerbel, Jan Kitajewski, Ingeborg Klaassen, Hynda K. Kleinmann, Pieter Koolwijk, Elisabeth Kuczynski, Brenda R. Kwak, Koen M. Marien, Juan M. Melero‐Martin, Lance L. Munn, Roberto F. Nicosia, Agnès Noël, Jussi Nurro, Anna-Karin Olsson, Tatiana V. Petrova, Kristian Pietras, Роберто Пили, Jeffrey W. Pollard, Mark J. Post, Paul H.A. Quax, Gabriel A. Rabinovich, Marius Raica, Anna M. Randi, Doménico Ribatti, Curzio Rüegg, Reinier O. Schlingemann, Stefan Schulte‐Merker, Lois E. H. Smith, Jonathan W. Song, Steven A. Stacker, Jimmy Stalin, Amber N. Stratman, Maureen Van de Velde, Victor W.M. van Hinsbergh, Peter Vermeulen, Johannes Waltenberger, Brant M. Weinstein, Hong Xin, Bahar Yetkin-Arik, Seppo Ylä‐Herttuala, Mervin C. Yöder, Arjan W. Griffioen - Angiogenesis 2018 cited by 597

  7. Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials

    Authors: Hung‐Yang Kuo, Kabir A. Khan, Robert S. Kerbel - Nature Reviews Clinical Oncology 2024 cited by 98

  8. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR

    Authors: Khalid Al‐Nedawi, Brian Meehan, Robert S. Kerbel, A. C. Allison, Janusz Rak - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 660

  9. Establishment and Characterization of First Trimester Human Trophoblast Cells with Extended Lifespan

    Authors: Charles H. Graham, Teresa S. Hawley, Robert C. Hawley, John R. MacDougall, Robert S. Kerbel, Nelson K.S. Khoo, Peeyush K. Lala - Experimental Cell Research 1993 cited by 1,065

  10. Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

    Authors: John M.L. Ebos, Christina R. Lee, William Cruz‐Muñoz, Georg A. Bjarnason, James G. Christensen, Robert S. Kerbel - Cancer Cell 2009 cited by 1,701

  11. Antiangiogenic therapy: impact on invasion, disease progression, and metastasis

    Authors: John M.L. Ebos, Robert S. Kerbel - Nature Reviews Clinical Oncology 2011 cited by 676

  12. Drug rechallenge and treatment beyond progression—implications for drug resistance

    Authors: Elizabeth A. Kuczynski, Daniel J. Sargent, Axel Grothey, Robert S. Kerbel - Nature Reviews Clinical Oncology 2013 cited by 281

  13. ecancermedicalscience

    Authors: Gauthier Bouche, Nicolás André, Shripad Banavali, Frank Berthold, Alfredo Berruti, Guido Bocci, Giovanni Brandi, Ugo Cavallaro, Saverio Cinieri, Marco Colleoni, Giuseppe Curigliano, Teresa Di Desidero, Alexandru Eniu, Nicola Fazio, Robert S. Kerbel, Lisa Hutchinson, Urszula Ledzewicz, Elisabetta Munzone, Eddy Pasquier, O. Graciela Scharovsky, Yuval Shaked, Jaroslav Štěrba, Martín Villalba, Francesco Bertolini - ecancermedicalscience 2016 cited by 679

  14. Non-angiogenic tumours and their influence on cancer biology

    Authors: Tom Dønnem, Andrew R. Reynolds, Elizabeth A. Kuczynski, Kevin C. Gatter, Peter Vermeulen, Robert S. Kerbel, Adrian L. Harris, Francesco Pezzella - Nature reviews. Cancer 2018 cited by 149

  15. Tumors resurrect an embryonic vascular program to escape immunity

    Authors: Elisabeth J. M. Huijbers, Kabir A. Khan, Robert S. Kerbel, Arjan W. Griffioen - Science Immunology 2022 cited by 55

  16. The anti-angiogenic basis of metronomic chemotherapy

    Authors: Robert S. Kerbel, Barton A. Kamen - Nature reviews. Cancer 2004 cited by 1,395

  17. Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1

    Authors: Chris Folkins, Yuval Shaked, Shan Man, Terence Tang, Christina R. Lee, Zhenping Zhu, Robert M. Hoffman, Robert S. Kerbel - Cancer Research 2009 cited by 372

  18. Vessel co‐option is common in human lung metastases and mediates resistance to anti‐angiogenic therapy in preclinical lung metastasis models

    Authors: Victoria L. Bridgeman, Peter Vermeulen, Shane Foo, Ágnes Bilecz, Frances Daley, Eleftherios Kostaras, Mark R. Nathan, Elaine Y. Wan, Sophia Frentzas, Thomas Schweiger, Balázs Hegedűs, Konrad Höetzenecker, F Rényi-Vámos, Elizabeth A. Kuczynski, Naveen Vasudev, James Larkin, Martin Gore, Harold F. Dvorak, Sándor Paku, Robert S. Kerbel, Balázs Döme, Andrew R. Reynolds - The Journal of Pathology 2016 cited by 209

  19. Mouse models of advanced spontaneous metastasis for experimental therapeutics

    Authors: Giulio Francia, William Cruz‐Muñoz, Shan Man, Ping Xu, Robert S. Kerbel - Nature reviews. Cancer 2011 cited by 373

  20. Forty-Year Journey of Angiogenesis Translational Research

    Authors: Yihai Cao, Jack L. Arbiser, Robert J. D’Amato, Patrìcia A. D'Amore, Donald E. Ingber, Robert S. Kerbel, Michael Klagsbrun, Sharon Lim, Marsha A. Moses, Bruce R. Zetter, Harold F. Dvorak, Róbert Langer - Science Translational Medicine 2011 cited by 223

  21. Clinical translation of angiogenesis inhibitors

    Authors: Robert S. Kerbel, Judah Folkman - Nature reviews. Cancer 2002 cited by 1,512

  22. Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect

    Authors: Guido Bocci, Robert S. Kerbel - Nature Reviews Clinical Oncology 2016 cited by 205

  23. β1-6 Branching of Asn-Linked Oligosaccharides Is Directly Associated with Metastasis

    Authors: James W. Dennis, Suzanne Laferté, Carol Waghorne, Martin L. Breitman, Robert S. Kerbel - Science 1987 cited by 942

  24. Effects of Aging and Hypoxia-Inducible Factor-1 Activity on Angiogenic Cell Mobilization and Recovery of Perfusion After Limb Ischemia

    Authors: Marta Bosch‐Marcé, Hiroaki Okuyama, Jacob Wesley, Kakali Sarkar, Hideo Kimura, Ye V. Liu, Huafeng Zhang, Marianne Strazza, Sergio Rey, Lindsey Savino, Yi Zhou, Karin R. McDonald, Youn Na, Scott Vandiver, Alireza Rabi, Yuval Shaked, Robert S. Kerbel, Theresa LaVallee, Gregg L. Semenza - Circulation Research 2007 cited by 289